ReviewEndocrine reviews2025

Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway.

Mila S Welling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.